ArticleRedox biology2026

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Bente Sandvei Skeie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.